The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Abstract
It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated HIF-1 plays a crucial role in adaptive responses of the tumor cells to changes in oxygen through transcriptional activation of over 100 downstream genes which regulate vital biological processes required for tumor survival and progression.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1 mediates this metabolic conversion through the induction of enzymes involved in the glycolysis pathway and overexpression of glucose transporters (GLUTs) which increase glucose import into tumor cells3.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1α is activated due to blockade of its degradation pathway mediated by low oxygen levels, thereby increasing the expression of target genes, including those encoding glycolytic enzymes and glucose transporters, and increasing lactate secretion67.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [67]
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Tumour cells respond to these conditions, and adapt their metabolism to adjust the O 2 demand to meet the limited suppl”
Background
Cited by
Items 201–300 of 1,002
Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH
Anemone, A., Consolino, L., Arena, F., Capozza, M., & Longo, D. L. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09782-9 · Cited by 162
Kluza, J., Corazao-Rozas, P., Touil, Y. S., Jendoubi, M., Maire, C., Guerreschi, P., Jonneaux, A., Ballot, C., Balayssac, S., Valable, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0979 · Cited by 174
Enzyme Mimics for Engineered Biomimetic Cascade Nanoreactors: Mechanism, Applications, and Prospects
Zhang, X., Li, G., Chen, G., Wu, D., Wu, Y., & James, T. D. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106139 · Cited by 159
Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells
Qin, W., Li, C., Zheng, W., Guo, Q., Zhang, Y., Kang, M., Zhang, B., Yang, B., Li, B., Yang, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5674 · Cited by 172
Patra, M., Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510551 · Cited by 160
UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer
Hu, Q., Qin, Y., Ji, S., Xu, W., Liu, W., Sun, Q., Zhang, Z., Liu, M., Ni, Q., Yu, X., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.024 · Cited by 165
Metal-organic frameworks for multimodal bioimaging and synergistic cancer chemotherapy
Zhang, Z., Sang, W., Xie, L., & Dai, Y. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.213022 · Cited by 159
The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
Luo, D., Wang, Z., Wu, J., Jiang, C., & Wu, J. (2014) · BioMed Research International · doi:10.1155/2014/409272 · Cited by 166
Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
van Kuijk, S. J. A., Yaromina, A., Houben, R. M. A., Niemans, R., Lambin, P., & Dubois, L. J. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00069 · Cited by 168
The tumour–stroma ratio in colon cancer: the biological role and its prognostic impact
van Pelt, G. W., Sandberg, T. P., Morreau, H., Gelderblom, H., van Krieken, J. H. J. M., Tollenaar, R. A. E. M., & Mesker, W. E. (2018) · Histopathology · doi:10.1111/his.13489 · Cited by 155
Shen, J., Rees, T. W., Ji, L., & Chao, H. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214016 · Cited by 159
Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies
Olson, K. A., Schell, J. C., & Rutter, J. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.01.002 · Cited by 154
Sack, M., Alili, L., Karaman, E., Das, S., Gupta, A., Seal, S., & Brenneisen, P. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0950 · Cited by 154
iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
Goldenson, B. H., Hor, P., & Kaufman, D. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841107 · Cited by 159
Bench-to-bedside review: Glucose and stress conditions in the intensive care unit
Losser, M.-R., Damoisel, C., & Payen, D. M. (2010) · Critical Care · doi:10.1186/cc9100 · Cited by 169
The regulation of cellular metabolism by tumor suppressor p53
Liang, Y., Liu, J., & Feng, Z. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-9 · Cited by 171
AMP kinase promotes glioblastoma bioenergetics and tumour growth
Chhipa, R. R., Fan, Q., Anderson, J., Muraleedharan, R., Huang, Y., Ciraolo, G. M., Chen, X., Waclaw, R. R., Chow, L. M. L., Khuchua, Z. A., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0126-z · Cited by 163
Iron in the Tumor Microenvironment-Connecting the Dots
Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00549 · Cited by 151
HIF1α Represses Cell Stress Pathways to Allow Proliferation of Hypoxic Fetal Cardiomyocytes
Guimarães‐Camboa, N., Stowe, J. C., Aneas, I., Sakabe, N. J., Cattaneo, P., Henderson, L. M., Kilberg, M. S., Johnson, R. S., Chen, J., McCulloch, A. D., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.04.021 · Cited by 154
Taniguchi, C. M., Finger, E. C., Krieg, A. J., Wu, C., Diep, A. N., LaGory, E. L., Wei, K., McGinnis, L. M., Yuan, J., Kuo, C. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3294 · Cited by 164
Huang, H., Li, G., He, Y., Chen, J., Yan, J., Zhang, Q., Li, L., & Cai, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1404441 · Cited by 204
Hao, J., Ge, K., Chen, G., Dai, B., & Li, Y. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00356f · Cited by 150
Manivasagan, P., Joe, A., Han, H., Thambi, T., Selvaraj, M., Chidambaram, K., Kim, J., & Jang, E. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100197 · Cited by 161
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146
Myc Posttranscriptionally Induces HIF1 Protein and Target Gene Expression in Normal and Cancer Cells
Doe, M. R., Ascano, J. M., Kaur, M., & Cole, M. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2371 · Cited by 161
Zheng, X., Tang, H., Xie, C., Zhang, J., Wu, W., & Jiang, X. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201503067 · Cited by 151
Hypoxia‐Responsive Gene Editing to Reduce Tumor Thermal Tolerance for Mild‐Photothermal Therapy
Li, X., Pan, Y., Chen, C., Gao, Y., Liu, X., Yang, K., Luan, X., Zhou, D., Zeng, F., Han, X., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202107036 · Cited by 148
OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development
Wu, Z., Zuo, M., Zeng, L., Cui, K., Liu, B., Yan, C., Chen, L., Dong, J., Shangguan, F., Hu, W., et al. (2020) · EMBO Reports · doi:10.15252/embr.202050827 · Cited by 161
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target
Hur, H., Yi, X., Kim, Y. B., Lee, G., Shim, W., Yun, J., Ham, I., & Han, S. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1687 · Cited by 152
Genetic determinants of Tibetan high-altitude adaptation
Simonson, T. S., McClain, D. A., Jorde, L. B., & Prchal, J. T. (2011) · Human Genetics · doi:10.1007/s00439-011-1109-3 · Cited by 149
Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect
Weljie, A. M., & Jirik, F. R. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.009 · Cited by 155
Baracca, A., Chiaradonna, F., Sgarbi, G., Solaini, G., Alberghina, L., & Lenaz, G. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.11.006 · Cited by 146
Wei, J., Huang, K., Hu, M., Chen, Z., Bai, Y., Lin, S., & Du, H. (2020) · Cancers · doi:10.3390/cancers12071788 · Cited by 175
M2‐like macrophage polarization in high lactic acid‐producing head and neck cancer
Ohashi, T., Aoki, M., Tomita, H., Akazawa, T., Sato, K., Kuze, B., Mizuta, K., Hara, A., Nagaoka, H., Inoue, N., et al. (2017) · Cancer Science · doi:10.1111/cas.13244 · Cited by 148
p53 and glucose metabolism: an orchestra to be directed in cancer therapy
Gomes, A. S., Ramos, H., Soares, J., & Saraiva, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.015 · Cited by 148
Fenton reaction-based nanomedicine in cancer chemodynamic and synergistic therapy
Meng, X., Zhang, X., Liu, M., Cai, B., He, N., & Wang, Z. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100864 · Cited by 150
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments
Marchetti, C., De Felice, F., Romito, A., Iacobelli, V., Sassu, C. M., Corrado, G., Ricci, C., Scambia, G., & Fagotti, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.08.011 · Cited by 139
Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?
Papandreou, I., Golias, T., & Denko, N. C. (2010) · International Journal of Cancer · doi:10.1002/ijc.25728 · Cited by 162
Self-citationIntegrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
Ata, R., & Antonescu, C. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010189 · Cited by 149
SGLT-2 Inhibitors in Cancer Treatment—Mechanisms of Action and Emerging New Perspectives
Dutka, M., Bobiński, R., Francuz, T., Garczorz, W., Zimmer, K., Ilczak, T. P., Ćwiertnia, M., & Hajduga, M. B. (2022) · Cancers · doi:10.3390/cancers14235811 · Cited by 149
Mitochondrial Calcium Regulation of Redox Signaling in Cancer
Delierneux, C., Kouba, S., Shanmughapriya, S., Potier‐Cartereau, M., Trebak, M., & Hempel, N. (2020) · Cells · doi:10.3390/cells9020432 · Cited by 146
Chen, X., Mendes, B. B., Zhuang, Y., Conniot, J., Argandona, S. M., Melle, F., Sousa, D. P., Perl, D., Chivu, A., Patra, H. K., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c12416 · Cited by 143
Combined Fenton and starvation therapies using hemoglobin and glucose oxidase
Ranji‐Burachaloo, H., Reyhani, A., Gurr, P. A., Dunstan, D. E., & Qiao, G. G. (2019) · Nanoscale · doi:10.1039/c8nr09107b · Cited by 142
miR-210: Fine-Tuning the Hypoxic Response
Ivan, M., & Huang, X. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_10 · Cited by 142
Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas
Miranda‐Gonçalves, V., Granja, S., Martinho, O., Honavar, M., Pojo, M., Costa, B. M., Pires, M. M., Pinheiro, C., Cordeiro, M., Bebiano, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10114 · Cited by 136
The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells?
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Saavedra, E., Marín‐Hernández, Á., & Gallardo‐Pérez, J. C. (2009) · BioFactors · doi:10.1002/biof.31 · Cited by 148
Energy metabolism of leukemia cells: glycolysisversusoxidative phosphorylation
Suganuma, K., Miwa, H., Imai, N., Shikami, M., Gotou, M., Goto, M., Mizuno, S., Takahashi, M., Yamamoto, H., Hiramatsu, A., et al. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.512966 · Cited by 133
Zhou, L., Wang, Y., Zhou, M., Zhang, Y., Wang, P., Li, X., Yang, J., Wang, H., & Ding, Z. (2018) · Nature Communications · doi:10.1038/s41467-018-03914-5 · Cited by 147
Fu, Z., Mowday, A. M., Smaill, J. B., Hermans, I. F., & Patterson, A. V. (2021) · Cells · doi:10.3390/cells10051006 · Cited by 147
Central role of lactic acidosis in cancer cell resistance to glucose deprivation‐induced cell death
Wu, H., Ding, Z., Hu, D., Sun, F., Dai, C., Xie, J., & Hu, X. (2011) · The Journal of Pathology · doi:10.1002/path.3978 · Cited by 141
Odagiri, H., Kadomatsu, T., Endo, M., Masuda, T., Morioka, M. S., Fukuhara, S., Miyamoto, T. K., Kobayashi, E., Miyata, K., Aoi, J., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004612 · Cited by 130
Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells
Rasola, A., Neckers, L., & Picard, D. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.03.005 · Cited by 129
LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect
Xiang, S., Gu, H., Jin, L., Thorne, R. F., Zhang, X. D., & Wu, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711257115 · Cited by 129
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
Yu, L., Chen, X., Wang, L., & Chen, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7676 · Cited by 139
Idelevich, A., Rais, Y., & Ornan, E. M. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.230904 · Cited by 130
FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function
Jensen, K. S., Binderup, T., Jensen, K. T., Therkelsen, I., Borup, R., Nilsson, E., Multhaupt, H. A. B., Bouchard, C., Quistorff, B., Kjær, A., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.323 · Cited by 131
SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylation
Seo, K.-S., Park, J.-H., Heo, J. Y., Jing, K., Han, J., Min, K.-N., Kim, C., Koh, G. Y., Lim, K., Kang, G.-Y., et al. (2014) · Oncogene · doi:10.1038/onc.2014.76 · Cited by 131
Nonalcoholic fatty liver disease and obstructive sleep apnea
Aron‐Wisnewsky, J., Clément, K., & Pépin, J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.004 · Cited by 133
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
Avagliano, A., Fiume, G., Pelagalli, A., Sanità, G., Ruocco, M. R., Montagnani, S., & Arcucci, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00722 · Cited by 138
An, G., Guo, F., Liu, X., Wang, Z., Zhu, Y., Fan, Y., Xuan, C., Li, Y., Wu, H., Shi, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16192-x · Cited by 130
Regulation of CD47 expression in cancer cells
Huang, C.-Y., Ye, Z.-H., Huang, M., & Lu, J. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100862 · Cited by 138
Gong, W. J., Xu, J., Wang, Y., Min, Q., Chen, X., Zhang, W., Chen, J., & Zhan, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00865-0 · Cited by 136
Zhao, Q., Chu, Z., Zhu, L., Yang, T., Wang, P., Liu, F., Huang, Y., Zhang, F., Zhang, X., Ding, W., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00637 · Cited by 133
Bader, S. B., Dewhirst, M. W., & Hammond, E. M. (2020) · Cancers · doi:10.3390/cancers13010023 · Cited by 140
Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53
Zawacka‐Pankau, J., Grinkevich, V. V., Hünten, S., Nikulenkov, F., Gluch, A., Li, H., Enge, M., Kel, A. E., & Selivanova, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240812 · Cited by 139
Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer?
Lemarié, A., & Grimm, S. (2011) · Oncogene · doi:10.1038/onc.2011.167 · Cited by 140
Chiacchiera, F., Matrone, A., Ferrari, E., Ingravallo, G., Lo Sasso, G., Murzilli, S., Petruzzelli, M., Salvatore, L., Moschetta, A., & Simone, C. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.36 · Cited by 117
Glioblastoma, Cancer Stem Cells and Hypoxia
Bar, E. E. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00460.x · Cited by 136
CO2-sensitive tRNA modification associated with human mitochondrial disease
Lin, H., Miyauchi, K., Harada, T., Okita, R., Takeshita, E., Komaki, H., Fujioka, K., Yagasaki, H., Goto, Y., Yanaka, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04250-4 · Cited by 125
Wu, H., Pan, L., Gao, C., Xu, H., Li, Y., Zhang, L., Ma, L., Li, M., Sun, X., & Qin, H. (2019) · Molecules · doi:10.3390/molecules24101993 · Cited by 134
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
Li, T., Mao, C., Wang, X., Shi, Y., & Tao, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01733-5 · Cited by 128
Wang, H., Guo, Y., Wang, C., Jiang, X., Liu, H., Yuan, A., Yan, J., Hu, Y., & Wu, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120621 · Cited by 124
Nontranscriptional Role of Hif-1α in Activation of γ-Secretase and Notch Signaling in Breast Cancer
Villa, J. C., Chiu, D., Brandes, A., Escorcia, F. E., Villa, C. H., Maguire, W. F., Hu, C., de Stanchina, E., Simon, M. C., Sisodia, S. S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.028 · Cited by 144
Yu, M., Duan, X., Cai, Y., Zhang, F., Jiang, S., Han, S., Shen, J., & Shuai, X. (2019) · Advanced Science · doi:10.1002/advs.201900037 · Cited by 129
Ke, X., Fei, F., Chen, Y., Xu, L., Zhang, Z., Huang, Q., Zhang, H., Yang, H., Chen, Z., & Xing, J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs196 · Cited by 126
Molecular Pathogenesis of Hepatocellular Carcinoma
Ho, D. W., Lo, R. C., Chan, L., & Ng, I. O. (2016) · Liver Cancer · doi:10.1159/000449340 · Cited by 132
Treps, L., Faure, S., & Clere, N. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107805 · Cited by 135
Tang, W., Yáng, Z., He, L., Deng, L., Fathi, P., Zhu, S., Li, L., Shen, B., Wang, Z., Jacobson, O., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20860-3 · Cited by 124
de Prati, A. C., Butturini, E., Rigo, A., Oppici, E., Rossin, M., Boriero, D., & Mariotto, S. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25972 · Cited by 127
Li, Y., Sun, P., Zhao, L., Yan, X., Ng, D. K. P., & Lo, P. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202010005 · Cited by 121
Revisiting the Warburg Effect with Focus on Lactate
Kocianova, E., Piatrikova, V., & Golias, T. (2022) · Cancers · doi:10.3390/cancers14246028 · Cited by 138
Hyperpolarized [2-13C]-Fructose: A Hemiketal DNP Substrate for In Vivo Metabolic Imaging
Keshari, K. R., Wilson, D. M., Chen, A. P., Bok, R., Larson, P. E. Z., Hu, S., Criekinge, M. V., Macdonald, J. M., Vigneron, D. B., & Kurhanewicz, J. V. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9049355 · Cited by 121
Song, N., Huang, Y., Shi, H., Yuan, S., Ding, Y., Song, X., Fu, Y., & Luo, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2007 · Cited by 123
Policastro, L. L., Ibañez, I. L., Notcovich, C., Duran, H. A., & Podhajcer, O. L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4367 · Cited by 120
Ueda, S., Roblyer, D. M., Cerussi, A. E., Durkin, A. F., Leproux, A., Santoro, Y., Xu, S., O’Sullivan, T. D., Hsiang, D. J. B., Mehta, R. S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0056 · Cited by 120
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
Sun, Z., Zhang, Q., Yuan, W., Li, X., Chen, C., Guo, Y., Shao, B., Dang, Q., Zhou, Q., Wang, Q., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01705-9 · Cited by 123
Huang, C.-Y., Kuo, W.-T., Huang, Y.-C., Lee, T., & Yu, L. C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.149 · Cited by 127
Porphyrin‐Based Metal−Organic Framework Compounds as Promising Nanomedicines in Photodynamic Therapy
Yu, W., Zhen, W., Zhang, Q., Yan-chun, L., Luo, H., He, J., & Liu, Y. (2020) · ChemMedChem · doi:10.1002/cmdc.202000353 · Cited by 120
Hypoxia in Solid Tumors: How Low Oxygenation Impacts the “Six Rs” of Radiotherapy
Rakotomalala, A., Escande, A., Furlan, A., Meignan, S., & Lartigau, E. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.742215 · Cited by 127
HypoxamiRs and Cancer: From Biology to Targeted Therapy
Gee, H. E., Ivan, C., Călin, G. A., & Ivan, M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5639 · Cited by 123
Advances in nanomaterials for treatment of hypoxic tumor
Zou, M., Liu, W., Chen, H., Bai, X., Gao, F., Ye, J., Cheng, H. L., & Zhang, X. (2020) · National Science Review · doi:10.1093/nsr/nwaa160 · Cited by 124
Mandl, M., & Depping, R. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00032 · Cited by 139
Glycolysis determines dichotomous regulation of T cell subsets in hypoxia
Xu, Y., Chaudhury, A., Zhang, M., Savoldo, B., Metelitsa, L. S., Rodgers, J. R., Yustein, J. T., Neilson, J. R., & Dotti, G. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85834 · Cited by 121
O 2 Economizer for Inhibiting Cell Respiration To Combat the Hypoxia Obstacle in Tumor Treatments
Yu, W., Liu, T., Zhang, M., Wang, Z., Ye, J., Li, C., Liu, W., Li, R., Feng, J. X., & Zhang, X. (2019) · ACS Nano · doi:10.1021/acsnano.8b07852 · Cited by 170
Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia
Smolková, K., Bellancé, N., Scandurra, F. M., Genot, E. M., Gnaiger, E., Plecitá‐Hlavatá, L., Ježek, P., & Rossignol, R. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9267-x · Cited by 118
Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression
Uehara, I., & Tanaka, N. (2018) · Cancers · doi:10.3390/cancers10070219 · Cited by 120
The acidic microenvironment as a possible niche of dormant tumor cells
Peppicelli, S., Andreucci, E., Ruzzolini, J., Laurenzana, A., Margheri, F., Fibbi, G., Rosso, M. D., Bianchini, F., & Calorini, L. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2496-y · Cited by 117
Recent advances in heat shock proteins in cancer diagnosis, prognosis, metabolism and treatment
Yang, S., Xiao, H., & Cao, L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112074 · Cited by 121
The role of mitochondria in pulmonary vascular remodeling
Dromparis, P., Sutendra, G., & Michelakis, E. D. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0670-x · Cited by 114
Wu, H., Ying, M., & Hu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9746 · Cited by 120
Metadata
- Authors
- Denko, N. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Denko, Nicholas C.
- ORCID
- Denko, Nicholas C.
- Venue
- Nature Reviews Cancer
- Published
- 2008-08-14
- Volume
- 8
- Issue
- 9
- Pages
- 705-713
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2066379425
- Cited by
- 1,707
- References
- 126
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 93 · 2023: 113 · 2022: 141 · 2021: 149 · 2020: 115 · 2019: 120 · 2018: 126 · 2017: 94 · 2016: 115 · 2015: 78 · 2014: 95 · 2013: 79 · 2012: 77
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01CA067166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- hypoxia, HIF-1, glucose metabolism, solid tumors, aerobic glycolysis, Warburg effect, cancer metabolism, mitochondrial activity, tumor growth
- MeSH terms
- Cell Division, Glucose, Glycolysis, Humans, Mitochondria, Models, Biological, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.